Summary
Definition
History and exam
Key diagnostic factors
- presence of risk factors
- excessive worry for at least 6 months
- anxiety not confined to another mental health disorder
- anxiety not due to medication or substance
- muscle tension
- sleep disturbance
- fatigue
- restlessness
- irritability
- poor concentration
Other diagnostic factors
- headache
- sweating
- dizziness
- gastrointestinal symptoms
- muscle aches
- increased heart rate
- shortness of breath
- trembling
- exaggerated startle response
- chest pain
Risk factors
- family history of anxiety
- physical or emotional stress
- history of physical, sexual, or emotional trauma
- other anxiety disorder
- chronic physical health condition
- female sex
Diagnostic investigations
1st investigations to order
- clinical diagnosis
Investigations to consider
- thyroid function tests
- urine drug screen
- 24-hour urine for catecholamines, metanephrines, normetanephrines, and creatinine
- pulmonary function tests
- ECG
Treatment algorithm
anxiety symptoms meeting DSM-5-TR criteria
anxiety symptoms not meeting DSM-5-TR criteria
Contributors
Authors
Philip John Cowen, MD, FRCPsych, FMedSci
Professor of Psychopharmacology
Department of Psychiatry
University of Oxford
Oxford
UK
Disclosures
PJC declares that he has no competing interests.
Acknowledgements
Professor Philip John Cowen would like to gratefully acknowledge Dr Christopher Gale, Dr Richard P. Swinson, Dr Elizabeth Hoge, and Dr Phebe Tucker, previous contributors to this topic.
Disclosures
CG is an author of the Royal Australian and New Zealand College of Psychiatrists clinical practice guideline on social phobia, panic disorder, and generalised anxiety disorder. Otago University has commercial and research relationships with multiple pharmaceutical companies. He is an author of a number of references cited in this topic. RPS has personally received royalties for articles published in UpToDate (Wolters Kluwer) and the Compendium of Therapeutic Choices, 2nd edition (Canadian Pharmacists Association). EH is an author of a number of references cited in this topic. PT has conducted research for GlaxoSmithKline, Bristol-Myers Squibb, Wyeth Pharmaceuticals, Astra-Zeneca, Cephalon, Inc., and Ortho-McNeil. She has also consulted for Forest Pharmaceuticals and received honoraria from Pfizer, Inc. and Forest Pharmaceuticals.
Peer reviewers
Lori Davis, MD
Research Director
University of Alabama
School of Medicine Tuscaloosa Campus
College of Community Health Sciences
Tuscaloosa
AL
Disclosures
LD declares that she has no competing interests.
Arianna Di Florio, MD, PhD
Senior Clinical Lecturer
Division of Psychological Medicine and Clinical Neurosciences
Cardiff University
United Kingdom
Disclosures
ADF declares that she has no competing interests.
Elaine Lockhart, MD, BCH, BAO
Consultant in Paediatric Liaison Psychiatry
Royal Hospital for Children
Glasgow
United Kingdom
Disclosures
EL declares that she has no competing interests.
Differentials
- Panic disorder
- Social anxiety disorder
- Obsessive-compulsive disorder
More DifferentialsGuidelines
- Screening and diagnosis of mental health conditions during pregnancy and postpartum
- Treatment and management of mental health conditions during pregnancy and postpartum
More GuidelinesPatient information
Anxiety: what is it?
Anxiety: what treatments work?
More Patient information- Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer